Lantheus Holdings Aktie [WKN DE: A117UE / ISIN: US5165441032]

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (groß)	News + Adhoc	Bilanz/GuV	Termine	Zertifikate	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Optionsscheine	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV	Knock-Outs
Historisch	Analysen

Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Historisch

News + Analysen
News + Adhoc
Analysen
Kursziele

Fundamental
Bilanz/GuV
Schätzungen
Dividende/GV
Analysen

Unternehmen
Termine
Profil

zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs

Nachrichten zu Lantheus Holdings Inc

28.06.21		Pre-market Movers: NTLA, ABUS, ATOS, GTEC... (RTTNews)
14.06.21		Lantheus To Present Piflufolastat F 18 Data at the Virtual Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2021 Annual Meeting (Businesswire)
27.05.21		FDA Approves Lantheus Holdings' Imaging Agent For Prostate Cancer (RTTNews)
27.05.21		Lantheus Receives U.S. FDA Approval of PYLARIFY® (piflufolastat F 18) Injection, the First and Only Commercially Available PSMA PET Imaging Agent for Prostate Cancer (Businesswire)
21.05.21		Lantheus Holdings Announces Presentation Featuring 18F-DCFPyL PET/CT, its PSMA-Targeted Prostate Cancer Imaging Agent at the 2021 ASCO Annual Meeting (Businesswire)
20.05.21		Lantheus Holdings to Present at the Jefferies Virtual Healthcare Conference (Businesswire)
20.05.21		Will The Regulatory Catalyst Impact These 3 Small-cap Pharma Stocks This Month? (RTTNews)
04.05.21		Lantheus Holdings, Inc. Reports First Quarter 2021 Financial Results (Businesswire)
03.05.21		EXINI Diagnostics AB, a Lantheus Company, Receives CE Mark Clearance for aPROMISE in Europe (Businesswire)
02.05.21		Ausblick: Lantheus öffnet die Bücher zum abgelaufenen Quartal (finanzen.net)
20.04.21		Lantheus Holdings to Host First Quarter 2021 Earnings Conference Call and Webcast on May 4, 2021 at 8:00 a.m. Eastern Time (Businesswire)
07.04.21		Lantheus Expands R&D Leadership Team with Key New Hires (Businesswire)
01.04.21		Lantheus Announces Retirement of Michael P. Duffy, Senior Vice President and General Counsel (Businesswire)
30.03.21		Lantheus Acquires Rights to Innovative Imaging Biomarker Targeting Fibroblast Activation Protein (FAP) from Noria (Businesswire)
22.03.21		Lantheus Announces Presentation Featuring AZEDRA® (iobenguane I 131) at ENDO 2021 (Businesswire)
01.03.21		Lantheus Announces Publication of PyL™ (18F-DCFPyL) Results from Pivotal Studies (Businesswire)
25.02.21		Lantheus Reports Fourth Quarter and Full Year 2020 Financial Results (Businesswire)
23.02.21		Ausblick: Lantheus zieht Bilanz zum jüngsten Jahresviertel (finanzen.net)
12.02.21		Lantheus Holdings to Present at the 10th Annual SVB Leerink Global Healthcare Conference (Businesswire)
11.02.21		Lantheus Holdings to Host Fourth Quarter and Full Year 2020 Earnings Conference Call and Webcast on February 25, 2020 at 4:30 p.m. Eastern Time (Businesswire)
04.02.21		Lantheus Holdings Announces Presentations Featuring its PSMA-Targeted Pipeline Product Candidates at the 2021 ASCO GU Annual Meeting (Businesswire)
12.01.21		Lantheus Holdings Announces Submission of Drug Master File for NM-01 in the U.S. (Businesswire)
09.12.20		Lantheus Holdings Announces Acceptance and Priority Review of New Drug Application for PyLTM (18F-DCFPyL), a PSMA-Targeted Prostate Cancer PET Imaging Agent (Businesswire)
03.12.20		Lantheus Holdings, Inc. Announces Agreement to Sell Its Puerto Rico Radiopharmacy and PET Manufacturing Facility and Enter into Long-Term Supply Agreement (Businesswire)
24.11.20		Lantheus Holdings to Present at the 2020 Evercore ISI HealthCONx Conference (Businesswire)
19.11.20		After-Hours Market: Nuance, Sonos, Aquestive, Lantheus Gain; GoPro Slips (RTTNews)
18.11.20		Lantheus Holdings, Inc. Announces FDA Approval of DEFINITY® Room Temperature (Businesswire)
13.11.20		Lantheus Holdings Announces FDA Clearance for AI-Enabled Automated Bone Scan Index (aBSI) in Prostate Cancer on GE Healthcare’s Xeleris Platform (Businesswire)
09.11.20		CORRECTION: TIME CHANGE - Lantheus Holdings to Present at November 2020 Investor Conferences (Businesswire)
05.11.20		Lantheus Holdings, Inc. Reports Third Quarter 2020 Financial Results (Businesswire)
04.11.20		Lantheus Holdings to Present at November 2020 Investor Conferences (Businesswire)
29.10.20		Lantheus Enters into Strategic Collaboration with Insightec for Use of Microbubbles in Combination with MR-Guided Focused Ultrasound for Treatment of Glioblastoma and Neurodegenerative Conditions (Businesswire)
22.10.20		Lantheus Holdings to Host Third Quarter 2020 Earnings Conference Call and Webcast on November 5, 2020 at 8:00 a.m. Eastern Time (Businesswire)
08.10.20		Lantheus Holdings Announces Presentations at the 33rd Annual European Association of Nuclear Medicine (EANM) Virtual Congress (Businesswire)
30.09.20		Lantheus Holdings Submits New Drug Application to the U.S. FDA for PyL™ (18F-DCFPyL), a PSMA-Targeted Prostate Cancer Imaging Agent (Businesswire)
03.09.20		Lantheus Holdings to Present at the Wells Fargo 2020 Virtual Healthcare Conference (Businesswire)
12.08.20		Lantheus Holdings, Inc. Announces FDA Approval of VIALMIX® RFID Device for DEFINITY® (Businesswire)
30.07.20		Lantheus Holdings, Inc. Reports Second Quarter 2020 Financial Results (Businesswire)
29.07.20		Ausblick: Lantheus präsentiert Quartalsergebnisse (finanzen.net)
23.07.20		Lantheus Holdings to Host Second Quarter 2020 Earnings Conference Call on July 30, 2020 at 8:00 a.m. Eastern Time (Businesswire)
01.07.20		Lantheus Holdings to Showcase the Potential of PyL™ Imaging Agent at the Virtual Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2020 Annual Meeting (Businesswire)
22.06.20		Lantheus Completes Merger with Progenics (Businesswire)
16.06.20		Lantheus Stockholders Approve Share Issuance For Merger with Progenics (Businesswire)
16.06.20		Lantheus Holdings to Present at the BMO 2020 Prescriptions for Success Virtual Healthcare Conference (Businesswire)
20.05.20		Lantheus Holdings to Present at the Jefferies Virtual Healthcare Conference (Businesswire)
30.04.20		Lantheus Holdings, Inc. Reports First Quarter 2020 Financial Results (Businesswire)
16.04.20		Lantheus Holdings to Host First Quarter 2020 Earnings Conference Call on April 30, 2020 at 8:00 a.m. Eastern Time (Businesswire)
14.04.20		Velan Capital Agrees to Support Merger of Lantheus and Progenics (Businesswire)
09.04.20		Lantheus Holdings, Inc. Reports Preliminary Q1 Revenue Near Top End of Previously Disclosed Guidance Range; Withdraws 2020 Financial Guidance (Businesswire)
06.04.20		Lantheus Holdings, Inc. to Hold 2020 Annual Meeting of Stockholders Virtually (Businesswire)

Zurück | 1 | 2 | 3 | Weiter

Newssuche

Meistgelesene Nachrichten

Krypto-Rekorde voraus: Wall Street sieht Bitcoin bei 200.000 US-Dollar

STRABAG-CEO Klemens Haselsteiner verstirbt überraschend - STRABAG-Aktie verliert

RBI-Aktie unter Druck: Russisches Urteil zu STRABAG zwingt RBI-Tochter zu Rückstellung

Ripple auf dem Weg zu 100 US-Dollar in 2025?

Trump ruft eigenen Krypto-Coin "$TRUMP" ins Leben - Kryptocoin auch für Melania

Bitcoin Kurs Prognose: 150.000 US-Dollar in wenigen Tagen?

finanzen.net Apps

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.

JETZT MEHR ERFAHREN

Aktien ATX DAX EuroStoxx 50 Dow Jones NASDAQ 100 Nikkei 225 S&P 500

Kontakt - Impressum - Werbung

Sitemap - Datenschutz - Disclaimer - AGB - Privatsphäre-Einstellungen

Für die aufgeführten Inhalte kann keine Gewährleistung für die Vollständigkeit, Richtigkeit und Genauigkeit übernommen werden.
Kursinformationen von SIX Financial Information Deutschland GmbH. Verzögerung 15 Min. (Nasdaq, NYSE: 20 Min.).
© 1999-2025 finanzen.net GmbH

*Werbehinweise: Die Billigung des Basisprospekts durch die Bundesanstalt für Finanzdienstleistungsaufsicht ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.

⁵Hinweis zu Plus500: 82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren. Plus500UK Ltd ist zugelassen und reguliert durch Financial Conduct Authority (FRN 509909). Plus500CY Ltd authorized & regulated by CySEC (#250/14).

Währungsrechner News Devisen Dollarkurs Aktienkurse Bitcoin Rohstoffe Fonds

Portfolioname: Watchlistname:
Portfolio:
Name:
Typ:
ISIN:
Börse:
Anzahl:
Aktueller Kurs:
Kurszeit:
Kaufpreis:
Kaufdatum:	24.01.2025 02:03
Kaufwert:	EUR
	Hinzufügen Speichern